Pancreatobiliary diseases
Conditions
Interventions
Participants will be randomly assigned to receive midazolam intravenously, and outpatient pancreatobiliary endoscopic ultrasonography (EUS) will be performed under sedation.
Participants will be rando
Sponsors
Clinical Research Center, Yokohama Rosai Hospital, Japan Organization of Occupational Health and Safety
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients aged 18 years or older. 2.Patients scheduled to undergo outpatient EUS for evaluation of pancreatobiliary diseases. 3/Patients from whom written informed consent has been obtained.
Exclusion criteria
Exclusion criteria: 1.Patients undergoing upper gastrointestinal endoscopy on the same day as the EUS examination. 2.Patients who have already participated in this study. 3.Patients with an allergy to benzodiazepines. 4.Patients with acute angle-closure glaucoma. 5.Patients with myasthenia gravis. 6.Patients with an American Society of Anesthesiologists Physical Status (ASA-PS) classification of III or higher. 7.Pregnant or breastfeeding women. 8.Patients deemed inappropriate for participation in this study by the attending physician for any other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ate of achieving a Modified Aldrete score of 9 or higher at 30 minutes after completion of the procedure | — |
Countries
Japan
Contacts
Public ContactMasato Suzuki
Yokohama Rosai Hospital Department of Gastroenterology
Outcome results
None listed